Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - SHORT-TERM DEBT
Short-term Debt ANAB - AnaptysBio, Inc.
1.78 M
LAST VALUE
-23.16%
2 YEAR CAGR
-25.28%
5 YEAR CAGR
6.67%
10 YEAR CAGR